Author

Mason L. Victors

Recursion (United States)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Systems Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:deep learning· 2 Organism:human· 2 Research Focus:benchmarking· 1 Research Focus:drug response / drug discovery· 1 Assay:imaging· 1

Frequent Co-Authors

Berton A. EarnshawiD· 2 shared Imran S. HaqueiD· 2 shared Adeline S. Low· 1 shared Ben FogelsoniD· 1 shared Ben Mabey· 1 shared Ben Miller· 1 shared Brett L. HurstiD· 1 shared Chadwick T. Davis· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersSystems Biology

Berton A. EarnshawORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

RxRx3: Phenomics Map of Biology

Marta M. Fay, Oren Z. Kraus, Mason L. Victors, Lakshmanan Arumugam, Kamal Vuggumudi, John Urbanik, Kyle Hansen, Safiye Çelik, Nico Cernek, Ganesh Jagannathan, Jordan Christensen, Berton A. Earnshaw, Imran S. Haque, Ben Mabey

RxRx3 provides a large-scale high-content screening dataset combining CRISPR knockouts and small molecule treatments to enable machine learning research and biological discovery.

bioRxiv · Feb 7, 2023 · PreprintSystems Biology

Identification of potential treatments for COVID-19 through artificial intelligence-enabled phenomic analysis of human cells infected with SARS-CoV-2

Katie Heiser, Peter McLean, Chadwick T. Davis, Ben Fogelson, Hannah B. Gordon, Pamela Jacobson, Brett L. Hurst, Ben Miller, Ronald W. Alfa, Berton A. Earnshaw, Mason L. Victors, Yolanda T. Chong, Imran S. Haque, Adeline S. Low, Christopher C. Gibson

In an image-based screen of 1,670 compounds in SARS-CoV-2-infected human renal epithelial cells, remdesivir was the only antiviral with strong efficacy; chloroquine and hydroxychloroquine showed no benefit.

bioRxiv · Apr 21, 2020 · PreprintSystems Biology